Kalobios Pharmaceuticals
South San Francisco
About Kalobios Pharmaceuticals
KaloBios Pharmaceuticals provides medicines for respiratory diseases and certain cancers. The company is a biopharmaceutical company focused on advancing medicines for patients with neglected and rare diseases. They designed to overcome marketed antibody products.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Public
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $83.9M
- Funding stage: IPO
- Last round: Post-IPO Equity (Jul 2020)
- Ticker: nasdaq:KBIO
- Website: kalobios.com
Industries & Categories
Biotechnology
Social Profiles
Canonical: https://fsome.com/organization/kalobios-pharmaceuticals-2625320 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.